Drug distributing giant McKesson Corp. was slapped with an FDA warning letter for allegedly shipping pharmacies opioid products with pills missing or non-opioid replacements.
HHS' Office for Civil Rights said the record settlement total underscores how hospitals and insurers need to be proactive about data security.
The FDA is going after retail pharmacy giant Walgreens Boots Alliance for repeated violations involving selling tobacco products to minors. Walgreens says it's working to resolve those issues.
National pharmacy giant Walgreens agreed to settle two allegations that it defrauded the federal government and 39 states in elaborate overbilling schemes.
The CMS terminated an Ohio hospital's Medicare and Medicaid funding because it didn't serve enough patients. The hospital hopes the agency will delay the decision.
North Carolina's attorney general approved hospital giant HCA Healthcare's $1.5 billion acquisition of Asheville-based Mission Health, after nabbing commitments from HCA meant to protect the state's healthcare industry.
Pharma critic Rep. Elijah Cummings is probing a dozen manufacturers over their drug pricing strategies and a bipartisan duo is calling for the FTC and Justice Department to come down on Bristol-Myers Squibb's acquisition of Celgene.
Martin Gottesfeld said he has no regrets for the cyberattacks he orchestrated on Boston Children's Hospital and a treatment home in 2014, which cost the facilities tens of thousands of dollars and disrupted operations for days.
The Food and Drug Administration found an Akorn facility violated current good manufacturing practice regulations. The drugmaker's stock has taken a hit due to the warning letter.
EmblemHealth is required to cover gender reassignment surgery and pay $250,000 in civil rights penalties to the state after the attorney general reached a settlement with the not-for-profit insurer.
The U.S. Department of Justice has intervened in a whistle-blower lawsuit against Sutter Health that accuses the health system of submitting unsupported diagnosis codes to inflate its Medicare Advantage payments.
Federal and Massachusetts authorities allege Minneapolis-based Target violated federal and state False Claims Acts by automatically refilling Medicaid recipients' prescriptions and seeking payment from Medicaid.